HR-5725 : Still Just a Bill

Benefit Evaluation of Safe Treatment Act of 2018 or the BEST Act of 2018

This bill requires the Centers for Medicare & Medicaid Services to report on the availability of supplemental health care benefits for the prevention and treatment of substance use disorders under Medicare Advantage (MA) plans, including differences between MA plans for certain individuals with special needs and other MA plans.

Action Timeline

Action DateTypeTextSource
2018-05-23CommitteeReferred to the Subcommittee on Health.House committee actions
2018-05-09IntroReferralReferred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.House floor actions
2018-05-09IntroReferralReferred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.House floor actions
2018-05-09IntroReferralIntroduced in HouseLibrary of Congress

Policy Area :

Health
See Subjects
  • Congressional oversight
  • Drug, alcohol, tobacco use
  • Government studies and investigations
  • Health care coverage and access
  • Medicare

Related Bills

See Related Bills